Clinical-stage biotechnology company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV).
- AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego
- Amneal Acquires Saol Therapeutics’ Baclofen Franchise
- Saol Therapeutics Announces FDA Approval of LYVISPAH™ (baclofen) Oral Granules and the Divesture of its Plasma-derived Hyperimmune Portfolio
- Ellie Diagnostics Raises Growth Equity from Avego Healthcare Capital
- Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBV
- Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation